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Lung cancer is the leading cause of cancer-related death in the world, and the prevalence and mortality of lung cancer are still increasing dramatically. 1 The survival of lung cancer is still poor, with a 5-year survival rate below 20%. 2 Approximately 80% to 85% of lung cancers are non-small cell lung cancers (NSCLCs), and the most common subtype is adenocarcinoma. Lung adenocarcinomas are histologically and clinically heterogeneous. According to the new classification proposed by an international multidisciplinary expert panel from the International Association for the Study of Lung Cancer/ American Thoracic Society/European Respiratory Society in 2011, 3 invasive mucinous adenocarcinoma (IMA) is a variant of adenocarcinoma, with tumor cells that have a goblet or columnar morphology and abundant mucin with stromal invasion. 4 Growth patterns such as lepidic, acinar, papillary, and micropapillary can be seen in IMA, except solid. It has been reported that the new classification of lung adenocarcinoma is well correlated with prognosis. In nonmucinous adenocarcinoma, lepidic-predominant adenocarcinoma has a better 5-year survival rate compared with that of acinar-predominant adenocarcinoma. 5, 6 Invasive mucinous adenocarcinoma also has different growth patterns, among which the lepidic and acinar patterns are most commonly seen. Until now, to our knowledge, no study regarding prognostic and clinicopathologic aspects of IMAs with different growth patterns has been reported. Therefore, we investigated different types of IMAs, with the aim to distinguish the differences in clinicopathologic features and prognosis of IMA subgroups. 
Materials and Methods

Case Selection
From January 1999 to July 2011, a total of 2,236 patients with newly diagnosed primary lung adenocarcinoma were consecutively enrolled. Among them, 16 patients met the histologic criteria for lepidic-predominant IMA, and 10 patients met the criteria for acinar-predominant IMA. This study was approved by the Ethical Committee of Human Experimentation in the First Affiliated Hospital of Sun Yat-sen University and was performed in agreement with the Helsinki Declaration of 1975. A minimum of two H&E-stained slides of each case were reevaluated by two pathologists (H.L. and A.H.).
Diagnostic Criteria
The definition of IMA from the 2015 World Health Organization classification for lung adenocarcinoma was used: an adenocarcinoma with tumor cells that have a goblet or columnar morphology and abundant intracytoplasmic mucin. Macroscopy of IMA appears as a poorly circumscribed, soft, gelatinous tumor. Histopathology shows a goblet and/or columnar cell morphology with abundant intracytoplasmic mucin and small basally oriented nuclei. 4 IMAs were divided into lepidic-predominant and acinar-predominant IMA, according to the growth pattern of tumor cells. Lepidic-predominant and acinar-predominant IMAs are defined as having a lepidic or an acinar pattern of more than 50%.
Clinical History
Medical records were retrieved for all cases enrolled in this study. Clinical presentation, tumor size, stage, and radiologic, therapeutic, and prognostic data were collected.
Statistical Analyses
Comparisons between groups were performed using the Student t test or one-way analysis of variance. The χ 2 test or Fisher exact test was used to analyze the relationship between subtypes and clinicopathologic characteristics. The Kaplan-Meier method was performed to plot survival curves while the log-rank test was used to compare survival curves. Univariate and Cox regression analysis tests were also performed to identify possible risk factors. A value of P < .05 was considered statistically significant. All statistical analyses were performed using SPSS 13.0 (SPSS, Chicago, IL).
Results
Patient Characteristics
From January 1999 to July 2011, of 2,236 patients with newly diagnosed primary lung adenocarcinoma, 16 (0.72%) had lepidic-predominant IMA and 10 (0.45%) had acinar-predominant IMA ❚Image 1❚. No statistically significant difference was noted in sex, age, and proportion of smokers between these two groups; nevertheless, the proportion of women and nonsmokers with lepidic-predominant IMA was much higher than those in general with acinar-predominant IMA. There was no statistically significant difference in the T classification in these subtypes. Lymph node metastasis was found in three cases of acinar-predominant IMA but none in lepidic-predominant IMA. The proportion of lymph node metastasis was significantly higher in acinar-predominant IMA (P = .046). All cases were classified as stages I to IIIA, according to the seventh edition of the TNM classification system. 7 The clinical characteristics of patients with lepidic-predominant and acinar-predominant IMA are summarized in ❚Table 1❚.
For lepidic-predominant IMA, eight (50.0%) cases were asymptomatic, while the most common symptoms were cough (n = 6) and sputum (n = 4). For acinar-predominant IMA, six (60.0%) cases were asymptomatic, while the most common symptoms were cough and sputum (n = 3). Of the 16 cases of lepidic-predominant IMA, eight (50.0%) tumors were located on the right side, and six (37.5%) were in the upper lobe. Of the 10 cases of acinar-predominant IMA, five (50.0%) tumors were located on the right side, and five (50.0%) were in the upper lobe. There was no significant difference in tumor location between these subtypes. Lepidic-predominant IMA tumors measured 1.8 to 13 cm (median, 5 cm) in the major dimension, while acinar-predominant IMA tumors measured 2.1 to 6 cm (median, 3 cm). Lepidicpredominant IMA seemed to have a larger tumor size than acinar-predominant IMA, but the difference did not reach statistical significance.
Comparison Between Lepidic-Predominant and Acinar-Predominant IMA on Computed Tomography
The computed tomography (CT) findings identified frequently in lepidic-predominant IMA included a lobulated margin (37.5%) and areas of ground-glass attenuation (31.3%), while those in acinar-predominant IMA were a lobulated margin (70.0%) and a spiculated margin (50.0%) ❚Image 2❚. However, no statistical significance was noted in margin characteristics in both subtypes. cases of lepidic-predominant IMA but in no cases of acinar-predominant IMA (Image 2A). Air bronchogram was found more frequently in lepidic-predominant IMA than in acinar-predominant IMA, but the difference did not reach statistical significance (P = .136). In terms of enhancement, low to moderate enhancement was found in all cases, without any statistical significance in enhancement degree. Of the 16 cases of lepidic-predominant IMA, five (31.2%) were misdiagnosed as infection according to the CT appearance; on the other hand, only one (10.0%) case of acinar-predominant IMA was misdiagnosed as infection before operation. The comparison of CT characteristics between lepidic-predominant and acinar-predominant IMA is summarized in ❚Table 2❚.
Survival Analyses Between Lepidic-Predominant and Acinar-Predominant IMA
On survival analyses of all 26 patients with IMA, the 5-year survival rate was 69.2%. In subgrouping analysis, the 5-year survival rate of patients with lepidic-predominant IMA was 81.3%, while the survival rate of patients with acinar-predominant IMA was 50.0%. Patients with acinar-predominant IMA exhibited a significantly poorer prognosis compared with patients with lepidic-predominant IMA (P = .0294) ❚Figure 1❚. Pathologic subtypes (lepidic predominant and acinar predominant), clinical stage, TNM classification, age, and sex were analyzed by using univariable Cox regression analyses. Univariable analyses revealed that clinical stage and pathologic subtypes were significant predictors of NSCLC ❚Table 3❚. 
Discussion
In this study, we have conducted a comparison between lepidic-predominant and acinar-predominant IMA, two common subtypes of lung IMA. To our knowledge, this is the first report on the clinical and CT features as well as survival differences between these two IMA subtypes. We have found that acinar-predominant IMA is associated with lymph node metastasis and has a poorer prognosis than lepidic-predominant IMA.
IMA is a clinically and genetically distinct subtype of invasive lung adenocarcinoma. Lung mucinous adenocarcinoma occurs at a greater frequency in female and nonsmoking patients, with a higher frequency in the lower lobe location. 8, 9 Lung IMA often has a single driver mutation with a low mutation burden. Previous studies have reported that the most frequent mutation is the KRAS mutation, and the most common gene fusions are CD74-NRG1 fusions. On the contrary, EGFR and TP53 mutations are uncommon in IMA. [9] [10] [11] [12] In our study, the proportion of female as well as nonsmoking patients with lepidic-predominant IMA was higher than those with acinar-predominant IMA. We also found that patients with IMA were often asymptomatic when diagnosed. Of the 26 patients with IMA, 14 (53.8%) were diagnosed at routine screening, which highlights the importance of lung cancer screening.
The results of previous studies regarding the prognosis of IMA have been conflicting. Yoshizawa et al 13 reported that IMA had a high incidence of recurrence. However, some recent studies have shown that IMA has a favorable prognosis and may not be aggressive. 8, 10 The conflicting results may be due to the low case incidence of IMA. However, differences in prognosis among subtypes of IMA have not been precisely analyzed. Here we propose that different subtypes of IMA may have a different prognosis, and the growth pattern could predict the prognosis of IMA. It has been reported that for nonmucinous adenocarcinoma, lepidic-predominant adenocarcinoma has a better 5-year survival rate compared with that of acinar-predominant adenocarcinoma. 5, 6 In our study, we have demonstrated that lepidic-predominant IMA also has a more favorable outcome than acinar-predominant IMA (P = .029). The 5-year survival rate of patients with acinar-predominant IMA was only 50.0%, whereas the survival rate of patients with lepidic-predominant IMA was 81.3%. The difference in survival rate between these two subtypes became more significant in long-term follow-up, as the 7-year survival rate of patients with acinar-predominant IMA declined to 25.0%, whereas that of lepidic-predominant IMA remained 65.0%. Therefore, we infer that an acinar-predominant pattern could be an indicator of poorer prognosis for both mucinous and nonmucinous lung adenocarcinoma. Growth pattern could be a predictor of prognosis in lung adenocarcinoma. However, this issue should be confirmed by further study with larger samples.
Of note in our study is the proportion of lymph node metastasis in patients with IMA. Of the 26 patients with IMA, only three (11.5%) showed lymph node metastasis. Interestingly, all the three cases belonged to the acinar-predominant IMA subgroup, and none of the lepidic-predominant IMA cases showed lymph node metastasis. Further statistical analysis showed that acinar-predominant IMA had a significantly higher rate of lymph node metastasis than lepidic-predominant IMA (P = .046). Our findings are consistent with previous studies that IMA is associated with a low incidence of lymph node metastasis. 14 Lee et al 8 reported that only 5% of patients with IMA had lymph node metastasis in their study. Nevertheless, we believe that different subtypes of IMA may have different lymph node metastasis rates. As lymph node metastasis is associated with poorer prognosis, the unfavorable outcome of acinar-predominant IMA could also be explained. There are few reports describing the CT patterns of IMA. It has been previously reported that the CT appearance of mucinous adenocarcinoma of the lung could be single nodules or diffuse nodules ("solitary type") or a segmental or lobar consolidation ("pneumonic type"). [15] [16] [17] However, the differences in CT appearance among the subgroups of IMA have not been explored in depth. In our study, no definite difference was found in the two subtypes. Interestingly, air bronchogram was found only in lepidic-predominant IMA but not in acinar-predominant IMA, which could be explained by the different growth patterns of tumor cells in these subtypes. However, the difference did not reach statistical significance. Further studies are needed to clarify this issue.
In conclusion, our study shows that lepidic-predominant and acinar-predominant IMAs are two different subtypes of IMA. Acinar-predominant IMA is associated with lymph node metastasis and has a poorer prognosis than lepidic-predominant IMA. Therefore, patients with acinar-predominant IMA should be closely followed after surgery. The acinar-predominant pattern could be an indicator of poorer prognosis for lung adenocarcinoma.
